These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Discovery of potent IDO1 inhibitors derived from tryptophan using scaffold-hopping and structure-based design approaches. Zou Y; Wang Y; Wang F; Luo M; Li Y; Liu W; Huang Z; Zhang Y; Guo W; Xu Q; Lai Y Eur J Med Chem; 2017 Sep; 138():199-211. PubMed ID: 28667875 [TBL] [Abstract][Full Text] [Related]
24. Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Williams DK; Markwalder JA; Balog AJ; Chen B; Chen L; Donnell J; Haque L; Hart AC; Mandal SK; Nation A; Shan W; Vite GD; Covello K; Hunt JT; Jure-Kunkel MN; Seitz SP Bioorg Med Chem Lett; 2018 Feb; 28(4):732-736. PubMed ID: 29398543 [TBL] [Abstract][Full Text] [Related]
25. New 4-Amino-1,2,3-Triazole Inhibitors of Indoleamine 2,3-Dioxygenase Form a Long-Lived Complex with the Enzyme and Display Exquisite Cellular Potency. Alexandre JAC; Swan MK; Latchem MJ; Boyall D; Pollard JR; Hughes SW; Westcott J Chembiochem; 2018 Mar; 19(6):552-561. PubMed ID: 29240291 [TBL] [Abstract][Full Text] [Related]
26. Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors. Zhou C; Lai F; Sheng L; Chen X; Li Y; Feng Z Molecules; 2020 Mar; 25(6):. PubMed ID: 32210078 [TBL] [Abstract][Full Text] [Related]
27. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Röhrig UF; Majjigapu SR; Vogel P; Zoete V; Michielin O J Med Chem; 2015 Dec; 58(24):9421-37. PubMed ID: 25970480 [TBL] [Abstract][Full Text] [Related]
28. Cell-Based Identification of New IDO1 Modulator Chemotypes. Hennes E; Lampe P; Dötsch L; Bruning N; Pulvermacher LM; Sievers S; Ziegler S; Waldmann H Angew Chem Int Ed Engl; 2021 Apr; 60(18):9869-9874. PubMed ID: 33565680 [TBL] [Abstract][Full Text] [Related]
30. The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors. Fallarini S; Bhela IP; Aprile S; Torre E; Ranza A; Orecchini E; Panfili E; Pallotta MT; Massarotti A; Serafini M; Pirali T ChemMedChem; 2021 Nov; 16(22):3439-3450. PubMed ID: 34355531 [TBL] [Abstract][Full Text] [Related]
31. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1. Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006 [TBL] [Abstract][Full Text] [Related]
32. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors. Gao D; Li Y Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475 [TBL] [Abstract][Full Text] [Related]
33. Diverse chemical space of indoleamine-2,3-dioxygenase 1 (Ido1) inhibitors. Singh R; Salunke DB Eur J Med Chem; 2021 Feb; 211():113071. PubMed ID: 33341650 [TBL] [Abstract][Full Text] [Related]
34. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO). Pan S; Zhou Y; Wang Q; Wang Y; Tian C; Wang T; Huang L; Nan J; Li L; Yang S Eur J Med Chem; 2020 Dec; 207():112703. PubMed ID: 32871341 [TBL] [Abstract][Full Text] [Related]
35. Discovery of IDO1 and DNA dual targeting antitumor agents. Fang K; Wu S; Dong G; Wu Y; Chen S; Liu J; Wang W; Sheng C Org Biomol Chem; 2017 Dec; 15(47):9992-9995. PubMed ID: 29177308 [TBL] [Abstract][Full Text] [Related]
36. Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors. Peng YH; Liao FY; Tseng CT; Kuppusamy R; Li AS; Chen CH; Fan YS; Wang SY; Wu MH; Hsueh CC; Chang JY; Lee LC; Shih C; Shia KS; Yeh TK; Hung MS; Kuo CC; Song JS; Wu SY; Ueng SH J Med Chem; 2020 Feb; 63(4):1642-1659. PubMed ID: 31961685 [TBL] [Abstract][Full Text] [Related]
37. A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Zheng Y; Stafford PM; Stover KR; Mohan DC; Gupta M; Keske EC; Schiavini P; Villar L; Wu F; Kreft A; Thomas K; Raaphorst E; Pasangulapati JP; Alla SR; Sharma S; Mittapalli RR; Sagamanova I; Johnson SL; Reed MA; Weaver DF ChemMedChem; 2021 Jul; 16(14):2195-2205. PubMed ID: 33759400 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388 [TBL] [Abstract][Full Text] [Related]
40. Heme-containing enzymes and inhibitors for tryptophan metabolism. Yan D; Lin YW; Tan X Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]